Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure

PHASE2TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

May 31, 2010

Conditions
Heart Failure
Interventions
DRUG

placebo

placebo patch

DRUG

testosterone

300 or 450 micrograms/day transdermal testosterone patch

Trial Locations (16)

11234

Research Site, Brooklyn

28403

Research Site, Wilmington

29651

Research Site, Greer

31406

Research Site, Savannah

32514

Research Site, Pensacola

32901

Research Site, Melbourne

37421

Research Site, Chattanooga

38138

Research Site, Germantown

46321

Research Site, Munster

78229

Research Site, San Antonio

85253

Research Site, Phoenix

85710

Research Site, Tucson

90712

Research Site, Lakewood

92501

Research Site, Riverside

98405

Research Site, Tacoma

06851

Research Site, Stamford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Warner Chilcott

INDUSTRY

NCT00957034 - Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure | Biotech Hunter | Biotech Hunter